Home > Current Investments

Current Investments

BPH Energy Ltd (BPH)

BPH Energy (previously BioPharmica Limited and then BPH Corporate) was formed in 2004 and is a listed company on the Australian Securities Exchange under code BPH.

BPH  has a 27.43% investment with Advent Energy Limited (Advent) which is an unlisted oil and gas exploration company. Advent holds a strong portfolio of exploration and near-term production assets throughout Australia. Advent’s cornerstone project lies off the coast of NSW in Petroleum Exploration Permit 11 (PEP11), and has been estimated to comprise up to 16.3 Tcf (P10 or ‘high’ level) prospective recoverable gas resources.

The company is commercialising a portfolio of Australian biomedical technologies emerging from research by leading Universities, Medical Institutes and Hospitals across Australia. Targeting large global markets BPH provides product development and commercial direction, whilst the institutional partner provides the majority of the infrastructure and research expertise.

Technologies on the way to commercialisation include: Cortical Dynamics Brain Anaesthesia Response (BAR) Monitor – a device that measures a patient’s brain electrical activity (EEG) to indicate the response to drugs administered during surgery; HLS5 Tumour Suppressor Gene – a molecular marker for early and accurate cancer detection; and microtubule drugs that target the tumour vasculature.

For further information click here


Molecular Discovery Systems (MDSystems)

Molecular Discovery Systems (MDSystems) is due to be listed on the Australian Securities Exchange (ASX) and has been spun out of BPH Energy Limited [ASX: BPH].  MDSystems was launched in 2006 and the main business of the company since its launch has been drug discovery and the validation of biomarkers for disease, therapy and diagnostics.  The company is now dedicated to all of the following technologies: Cancer Therapeutics and HLS5 Tumour Suppressor Gene.

For further information click here


Advent Energy Ltd

Advent Energy Limited (Advent) was formed in 2004 and is an unlisted oil and gas exploration and production company based in Perth, Western Australia.

Advent has assembled an attractive portfolio of assets both on and offshore Australia that have had an estimated $126 million spent on historic exploration. All permits are located next to a ready market and/or excellent infrastructure, thereby maximising Advent’s ability to optimise any resources.

Included in the portfolio is:

  • Petroleum Exploration Permit 11 (permit PEP11) in the offshore Sydney Basin. This permit has been assessed to contain up to 13.2 Tcf (P50 or ‘best estimate’ level) prospective recoverable gas resources adjacent to the major population region of Sydney and excellent port and power generation infrastructure.
  • Retention Lease 1 (RL1) and Exploration Permit 386 (EP386), in the Onshore Bonaparte Basin.

For further information click here